Spots Global Cancer Trial Database for BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC)
Official Title: LUX-Lung 6: A Randomized, Open-label, Phase III Study of BIBW 2992 Versus Chemotherapy as First-line Treatment for Patients With Stage IIIB or IV Adenocarcinoma of the Lung Harbouring an EGFR Activating Mutation
Study ID: NCT01121393
Study Description
Brief Summary: To investigate the efficacy and safety of BIBW 2992 compared to standard first-line chemotherapy in patients with stage IIIB or IV adenocarcinoma of the lung harbouring an EGFR activating mutation
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Beijing Chao-Yang Hospital, Beijing, , China
307 Hospital of PLA, Beijing, , China
Peking Union Medical College Hospital, Beijing, , China
Beijing Chest Hospital, Beijing, , China
First Hospital of Jilin University, Changchun, , China
Xiangya Hospital, Central South University, Changsha, , China
Hunan Province Tumor Hospital, Changsha, , China
West China Hospital, Chengdu, , China
Fujian Provincial Tumor Hospital, Fuzhou, , China
Guangdong General Hospital, Guangzhou, , China
Guangzhou Institute of Respiratory Disease, Guangzhou, , China
NanFang Hosptial, Guangzhou, , China
The Third Affiliated Hospital of Harbin Medical University, Haerbin, , China
Zhejiang Cancer Hospital, Hangzhou, , China
Hubei Cancer Hospital, HongShan, , China
Yunnan Provincial Tumor Hospital, Kunming, , China
Lin Yi Tumor Hospital, Linyi, , China
The Affiliated Cancer Hospital, Guangxi Medical University, Nan Ning, , China
the 81th Hospital of PLA, Nanjing, , China
Jiangsu Cancer Hospital, Nanjing, , China
The affiliated hospital of medicalcollege qingdao university, Qingdao, , China
Shanghai Changzheng Hospital, Shanghai, , China
Shanghai Chest Hospital, Shanghai, , China
Zhongshan Hospital Fudan University, Shanghai, , China
Shanghai Pulmonary Hospital, Shanghai, , China
Changhai Hospital, Shanghai, , China
The First Hospital of Chinese Medical University, Shenyang, , China
Hebei Provincial Tumor Hospital, Shijiazhuang, , China
Tangdu Hospital, Xi'An, , China
Northern Jiangsu People's Hospital, Yangzhou, , China
Kosin University Gospel Hospital, Busan, , Korea, Republic of
Chungbuk National University Hospital, Cheongju, , Korea, Republic of
Yeungnam University Medical Center, Daegu, , Korea, Republic of
Konkuk University Medical Center, Seoul, , Korea, Republic of
Korea University Guro Hospital, Seoul, , Korea, Republic of
Songklanagarind Hospital, Songkla, , Thailand
Contact Details
Name: Boehringer Ingelheim
Affiliation: Boehringer Ingelheim
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
